Mirizzi syndrome is a rare complication of long-standing gallstone disease and is defined as a partial or complete common bile duct obstruction caused by an impacted gallstone in the gallbladder neck or cystic duct. A subclassification of Mirizzi syndrome into type-I and II lesions has been proposed. Based on this classification a standardized surgical approach is now proposed. In a retrospective series of 18 cases with Mirizzi syndrome, found among 1,759 cholecystectomies performed since June 1986, we treated 7 type-I and 11 type-II lesions. There were 11 females and 7 males with an average age of 74.8 (range 32-87) years, and there was an increased incidence (27%) of concomitant gallbladder cancer found. All type-I lesions were treated by partial cholecystectomy, and 5 patients had concomitant exploration of the common bile duct with T-tube drainage. All type-II lesions received cholecystocholedochalenteric bypass surgery, namely 8 with a Roux-en-Y enterostomy and 3 with duodenostomy. Two patients (1 type-I+ and 1 type-II lesion) had a laparoscopic approach but needed conversion to open surgery because of severe inflammatory adhesions. There was no postoperative mortality and postoperative morbidity was low at 27% (5 of 18 patients). We had 1 case with postoperative bile leakage and 1 with hemorrhage. Three patients who had had biliary-enteric bypass procedures developed benign hepatic duct strictures which were all treated conservatively using endoscopic stenting. This management strategy has yielded very satisfactory results and laparoscopic surgery has been limited to a very small number of patients with type-I lesions.

Keywords:
Mirizzi syndrome, Laparoscopy, Gallbladder surgery, Bile duct fistula
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.